NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank88
3Y CAGR+432.8%
5Y CAGR+213.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+432.8%/yr
vs -74.9%/yr prior
5Y CAGR
+213.4%/yr
Recent acceleration
Acceleration
+507.7pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
302.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $605000.00 | +12000.0% |
| 2024 | $5000.00 | 0.0% |
| 2023 | $5000.00 | +25.0% |
| 2022 | $4000.00 | +100.0% |
| 2021 | $2000.00 | 0.0% |
| 2020 | $2000.00 | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $1.01M | - |
| 2017 | $0.00 | - |